O’Cathail, S.M.; Wu, C.-H.; Thomas, R.; Hawkins, M.A.; Maughan, T.S.; Lewis, A.
NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch. Antioxidants 2021, 10, 1380.
https://doi.org/10.3390/antiox10091380
AMA Style
O’Cathail SM, Wu C-H, Thomas R, Hawkins MA, Maughan TS, Lewis A.
NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch. Antioxidants. 2021; 10(9):1380.
https://doi.org/10.3390/antiox10091380
Chicago/Turabian Style
O’Cathail, Séan M., Chieh-Hsi Wu, Rachael Thomas, Maria A. Hawkins, Tim S. Maughan, and Annabelle Lewis.
2021. "NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch" Antioxidants 10, no. 9: 1380.
https://doi.org/10.3390/antiox10091380
APA Style
O’Cathail, S. M., Wu, C.-H., Thomas, R., Hawkins, M. A., Maughan, T. S., & Lewis, A.
(2021). NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch. Antioxidants, 10(9), 1380.
https://doi.org/10.3390/antiox10091380